{"entity":{"type":"insider","cik":"0001618247","url":"/insider/0001618247","json_url":"/insider/0001618247.json","name":"Morrison Jodie Pope","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2015-06-30","last":"2026-02-27","span_basis":"filed_date"},"name_variants":[{"name":"Morrison Jodie Pope","source":"filing","n_filings":5,"first_seen":"2015-06-30","last_seen":"2026-02-27"}],"transactions":[{"id":5809590,"accession":"0001193125-26-083585","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-083585","line_url":"/filing/0001193125-26-083585#line-1","is_derivative":false,"issuer_cik":"0001618247","issuer_name":"Q32 Bio Inc.","issuer_ticker":"QTTB","issuer_name_source":null,"issuer_url":"/issuer/0001618247","owner_cik":"0001618247","owner_name":"Morrison Jodie Pope","owner_url":"/insider/0001618247","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9896.0,"shares_display":"9,896","price_per_share":4.5144,"price_display":"4.51","price_state":"stated","total_value":44674.5024,"total_display":"44,674.50","shares_owned_after":89104.0,"shares_owned_after_display":"89,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-27","scope":"insider"},{"id":4991071,"accession":"0001193125-25-308328","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-308328","line_url":"/filing/0001193125-25-308328#line-1","is_derivative":false,"issuer_cik":"0001618247","issuer_name":"Q32 Bio Inc.","issuer_ticker":"QTTB","issuer_name_source":null,"issuer_url":"/issuer/0001618247","owner_cik":"0001618247","owner_name":"Morrison Jodie Pope","owner_url":"/insider/0001618247","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22506.0,"shares_display":"22,506","price_per_share":3.46,"price_display":"3.46","price_state":"stated","total_value":77870.76,"total_display":"77,870.76","shares_owned_after":99000.0,"shares_owned_after_display":"99,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-04","scope":"insider"},{"id":4372005,"accession":"0001193125-25-191452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-191452","line_url":"/filing/0001193125-25-191452#line-1","is_derivative":false,"issuer_cik":"0001618247","issuer_name":"Q32 Bio Inc.","issuer_ticker":"QTTB","issuer_name_source":null,"issuer_url":"/issuer/0001618247","owner_cik":"0001618247","owner_name":"Morrison Jodie Pope","owner_url":"/insider/0001618247","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10494.0,"shares_display":"10,494","price_per_share":1.801,"price_display":"1.80","price_state":"stated","total_value":18899.694,"total_display":"18,899.69","shares_owned_after":121506.0,"shares_owned_after_display":"121,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-28","scope":"insider"},{"id":8587817,"accession":"0001562180-15-000624","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-15-000624","line_url":"/filing/0001562180-15-000624#line-6","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Tokai Pharmaceuticals Inc","issuer_ticker":"TKAI","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001618247","owner_name":"Morrison Jodie Pope","owner_url":"/insider/0001618247","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":564.0,"shares_display":"564","price_per_share":13.7,"price_display":"13.70","price_state":"stated","total_value":7726.8,"total_display":"7,726.80","shares_owned_after":19551.0,"shares_owned_after_display":"19,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-29","filed_date":"2015-07-30","scope":"insider"},{"id":8587811,"accession":"0001562180-15-000624","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-15-000624","line_url":"/filing/0001562180-15-000624#line-2","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Tokai Pharmaceuticals Inc","issuer_ticker":"TKAI","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001618247","owner_name":"Morrison Jodie Pope","owner_url":"/insider/0001618247","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":13.7,"price_display":"13.70","price_state":"stated","total_value":164400.0,"total_display":"164,400.00","shares_owned_after":19551.0,"shares_owned_after_display":"19,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-28","filed_date":"2015-07-30","scope":"insider"},{"id":8706123,"accession":"0001562180-15-000533","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-15-000533","line_url":"/filing/0001562180-15-000533#line-4","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Tokai Pharmaceuticals Inc","issuer_ticker":"TKAI","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001618247","owner_name":"Morrison Jodie Pope","owner_url":"/insider/0001618247","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":13.7,"price_display":"13.70","price_state":"stated","total_value":109600.0,"total_display":"109,600.00","shares_owned_after":9551.0,"shares_owned_after_display":"9,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-29","filed_date":"2015-06-30","scope":"insider"},{"id":8706121,"accession":"0001562180-15-000533","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-15-000533","line_url":"/filing/0001562180-15-000533#line-2","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Tokai Pharmaceuticals Inc","issuer_ticker":"TKAI","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001618247","owner_name":"Morrison Jodie Pope","owner_url":"/insider/0001618247","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":13.83,"price_display":"13.83","price_state":"stated","total_value":110640.0,"total_display":"110,640.00","shares_owned_after":9551.0,"shares_owned_after_display":"9,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-26","filed_date":"2015-06-30","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001661998","name":"Q32 Bio Inc.","url":"/issuer/0001661998","role":"Director, Officer (CEO)","n_filings":3,"first_seen":"2025-08-28","last_seen":"2026-02-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001404281","name":"Tokai Pharmaceuticals Inc","url":"/issuer/0001404281","role":"Director, Officer (President and CEO)","n_filings":2,"first_seen":"2015-06-30","last_seen":"2015-07-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001618247","retrieved_at":"2026-08-22T04:17:05+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}